Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors

Oncology Reports

Volumn 8, Issue 6, 2001, Pages 1265-1267

  Jeon, Sung Hyun ^a   Lee, Sun J ^a   Chang, Sung Goo ^a,b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Superficial bladder tumor; Urinary vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; BLADDER TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; URINE;

BIOLOGICAL MARKERS; CARCINOMA, TRANSITIONAL CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035511776     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.6.1265     Document Type: Article

References (13)

1. Folkman J: What is the evidence that tumor are angiogenesis dependent? N Engl J Med 285: 82-86, 1990.
2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
3. Ferrara N and Davis-Smith TD: The biology of vascular endothelial growth factor. Endocr Rev 10: 4-25, 1997.
4. O'Brien TS, Cranston D, Fuggle S, et al: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55: 510-513, 1995.
5. Zhang HT, Craft P, Scott PA, et al: Enhancement of tumor growth and vascularity by transfection of vascular endothelial growth factor into MCF-7 breast carcinoma cells. J Natl Cancer Inst 87: 213-219, 1995.
6. Kim KJ, Li B, Winer J, et al: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844, 1993.
7. Skobe M, Rockwell P, Goldstein N, et al: Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 3: 1222-1227, 1997.
8. Crew JP, O'Brien T, Bicknell R, et al: Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol 161: 799-804, 1999.
9. Choi JH and Chang S-G: Clinical impact of urinary vascular endothelial growth factor (VEGF) in patient with transitional cell carcinoma of the bladder. Korean J Urol 39: 573-579, 1998.
10. Melder RA, Koenig GC, Winter BP, et al: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2: 992-997, 1996.
11. Gabrilovich DI, Chen HL, Girgis KR, et al: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2: 1096-1103, 1996.
12. Saleh M, Stacker SA and Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401, 1996.
13. Kim KI, Li B, Houk K, et al: The vascular endothelial growth factor proteins: identification of biologically relevant region by neutralizing monoclonal antibodies. Growth Factors 7: 53-64, 1992.